Nasonex Nasal Spray
Nasonex Nasal Spray

53.5
A generic medicine indicated for respiratory conditions. Reduces inflammation in the nasal passages and addresses congestion caused by seasonal airborne triggers.


Ingredient
Availability
In Stock
Delivery Time
Airmail (14-21 days) | Trackable (5-9 days)
Shipped in a discreet, unmarked envelope with all required documents enclosed.

Product Sheet

Active Ingredient(s)
Mometasone furoate monohydrate
Reference Brand
Mometasone furoate
Product Origin
Generic Brand
Product Manufacturer
Merck
Product Form
Nasal Spray
Regulatory Classification
Prescription Only Medicine
Primary Category
Skin Care
Product Category
Glucocorticoid
Pharmacological Class
Corticosteroid Nasal Spray
Clinical Indications
Manufacturer Description
Developed to mitigate nasal allergic congestion to support clear breathing passages and target mucosal swelling.
Mechanism of Action
Inhibits multiple inflammatory cells and decreases localized cytokine output to resolve mucosal vascular edema.
Route of Administration
Nasal
Onset Time
12–24 hours
Duration
24 hours
Contraindications
Hypersensitivity to mometasone
Severe Adverse Events
Nasal septal perforation — requires immediate medical attention
Common Side Effects
Nasal burning, Sneezing, Headache
Uncommon Side Effects
Epistaxis, Throat irritation, Nasal ulceration
Drug Interactions
Ketoconazole
Pregnancy Safety Warnings
TGA Category C: Use if potential benefits outweigh risks. Breastfeeding: Consult a doctor.
Age Restrictions
Approved for children over two years and adults.
Storage Guidelines
Store between 2°C and 25°C. Do not freeze.
Related Products
Information related to Nasonex Nasal Spray is compiled and periodically reviewed with reference to established medical sources and prescribing guidance. Content is provided for general reference and should be confirmed with a registered healthcare professional before use.
Categories
where to order Hair Regrowth Australia - Avodart Australia